Yohei Miyamoto Selected Research

Yohei Miyamoto Research Topics

Disease

7	Pruritus (Itching) 01/2022 - 05/2010
7	Glomerulonephritis 09/2017 - 04/2005
5	Chronic Renal Insufficiency 01/2017 - 04/2011
4	Fibrosis (Cirrhosis) 09/2017 - 08/2007
2	Liver Diseases (Liver Disease) 01/2022 - 01/2016
2	Neuralgia (Stump Neuralgia) 01/2019 - 11/2010
2	Familial Primary Pulmonary Hypertension 02/2017 - 10/2008
2	Renal Insufficiency (Renal Failure) 08/2008 - 02/2004
1	Idiopathic Pulmonary Fibrosis 12/2023
1	Hypertension (High Blood Pressure) 01/2018
1	Lymphoma (Lymphomas) 09/2017
1	Neoplasms (Cancer) 09/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2017
1	Breast Neoplasms (Breast Cancer) 02/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypertrophy 04/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2015
1	Hyperuricemia 01/2015
1	Proteinuria 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2013
1	Acute Kidney Injury (Acute Renal Failure) 11/2012
1	Crohn Disease (Crohn's Disease) 10/2011
1	Autoimmune Diseases (Autoimmune Disease) 10/2011
1	Substance-Related Disorders (Drug Abuse) 11/2010
1	Schizophrenia (Dementia Praecox) 11/2010
1	Pain (Aches) 11/2010
1	Dyskinesias (Dyskinesia) 11/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010

Drug/Important Bio-Agent (IBA)

6	TRK 820IBA 01/2022 - 05/2010
4	AntipruriticsIBA 10/2016 - 11/2010
4	Biomarkers (Surrogate Marker)IBA 11/2013 - 10/2011
3	Proteins (Proteins, Gene)FDA Link 02/2017 - 12/2009
3	Epidermal Growth Factor (EGF)IBA 11/2013 - 11/2012
3	CalbindinsIBA 11/2013 - 11/2012
3	Cystatin CIBA 11/2013 - 11/2012
3	OsteopontinIBA 11/2013 - 11/2012
3	ClusterinIBA 11/2013 - 11/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013 - 11/2012
2	BenzbromaroneIBA 01/2018 - 01/2015
2	AntioxidantsIBA 01/2018 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 08/2007
2	vitamin K1 oxideIBA 09/2017 - 07/2012
2	Oxidoreductases (Dehydrogenase)IBA 09/2017 - 07/2012
2	Vitamin K FDA Link 09/2017 - 05/2008
2	3-acetyl-5-methyltetronic acidIBA 09/2017 - 07/2012
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2017 - 10/2008
2	beraprostIBA 02/2017 - 10/2008
2	Opioid Analgesics (Opioids)IBA 10/2016 - 07/2012
2	Phenobarbital (Luminal)FDA Link 04/2016 - 07/2009
2	Sulfates (Sulfates, Inorganic)IBA 02/2015 - 04/2013
2	CreatinineIBA 01/2015 - 11/2013
2	Urea (Carbamide)FDA LinkGeneric 01/2015 - 07/2009
2	NitrogenIBA 01/2015 - 07/2009
2	Lipocalin-2IBA 11/2013 - 07/2013
2	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2013 - 07/2013
2	Metalloproteases (Metalloproteinases)IBA 11/2013 - 07/2013
2	CytokinesIBA 04/2013 - 09/2011
2	Catechin (Z 7300)IBA 08/2008 - 02/2004
2	gallocatechol (epigallocatechin)IBA 08/2008 - 02/2004
2	TeaIBA 08/2008 - 02/2004
1	Small Interfering RNA (siRNA)IBA 12/2023
1	OligonucleotidesIBA 12/2023
1	piperidineIBA 01/2019
1	imidazoleIBA 01/2019
1	Angiotensin IIIBA 01/2018
1	SaltsIBA 01/2018
1	anti-Thy antibodyIBA 09/2017
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 02/2017
1	Organic Anion TransportersIBA 02/2017
1	Multidrug Resistance-Associated Protein 2IBA 02/2017
1	Organic Cation Transporter 1IBA 02/2017
1	AnionsIBA 02/2017
1	Peptides (Polypeptides)IBA 02/2017
1	Organic Cation Transporter 2IBA 02/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2017
1	TabletsIBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2016
1	Clofibrate FDA Link 04/2016
1	EnzymesIBA 04/2016
1	Hematoxylin (Haematoxylon)IBA 04/2016
1	LipidsIBA 04/2016
1	furanIBA 01/2016
1	IsoenzymesIBA 01/2015
1	antiglomerular basement membrane antibodyIBA 11/2013
1	Messenger RNA (mRNA)IBA 04/2013
1	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013
1	Alanine Transaminase (SGPT)IBA 10/2011
1	p38 Mitogen-Activated Protein KinasesIBA 10/2011
1	doramapimodIBA 10/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2011
1	Uremic ToxinsIBA 09/2011
1	IndicanIBA 04/2011
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2010
1	Naltrexone (ReVia)FDA LinkGeneric 09/2010
1	Narcotic Antagonists (Opioid Antagonists)IBA 09/2010
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 02/2010
1	DNA (Deoxyribonucleic Acid)IBA 02/2010

Therapy/Procedure

6	Renal Dialysis (Hemodialysis) 01/2022 - 05/2010
3	Oral Administration 01/2018 - 05/2008
1	Peritoneal Dialysis 01/2022